Takahiro Horie

Title: Takahiro Horie: Innovator in Cardiomyocyte and Neurodegenerative Disease Research

Introduction

Takahiro Horie is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the fields of cardiomyocyte protection and neurodegenerative disease treatment. With a total of 2 patents, his work is paving the way for advancements in medical therapies.

Latest Patents

Horie's latest patents include a composition for protecting cardiomyocytes. The inventors have discovered that the compounds of formula (I) protect cardiomyocytes. This pharmaceutical composition is designed to treat or prevent diseases associated with cardiomyocyte death, such as myocardial infarction, chronic heart failure, hypertensive heart failure, or dilated cardiomyopathy, with a particular focus on treating myocardial infarction. Another significant patent is a composition for preventing or treating neurodegenerative diseases. This invention aims to provide a therapeutic agent for hereditary spastic paraplegia (HSP) SPG4. The composition comprises a substance that inhibits the function of miR-33a, targeting neurodegenerative diseases effectively.

Career Highlights

Takahiro Horie is affiliated with Kyoto University, where he conducts his research and development. His work has garnered attention for its potential impact on treating serious health conditions.

Collaborations

Horie collaborates with notable colleagues, including Koh Ono and Akira Kakizuka. Their combined expertise enhances the research and development of innovative medical solutions.

Conclusion

Takahiro Horie's contributions to cardiomyocyte protection and neurodegenerative disease treatment highlight his role as a leading inventor in the medical field. His patents reflect a commitment to advancing healthcare solutions that can significantly improve patient outcomes.